Global /United States /Healthcare /Medical Devices /VVOS
chevron_leftBack
Vivos Therapeutics, Inc. logo

Vivos Therapeutics, Inc.

VVOS
NASDAQ: VVOS Delayed
0.7817USD -8%
As of 14 June 2026, Vivos Therapeutics, Inc. has a market cap of $10.54M USD, ranking #41012 globally and #5305 in the United States. It ranks #3645 in the Healthcare sector, and #771 in the Medical Devices industry.
Global Rank
41012
Country Rank
5305
Sector Rank
3645
Industry Rank
771
Key Stats
Market Cap
$10.54MUSD
Enterprise Value
$22.8MUSD
Revenue (TTM)
$17.44MUSD
EBITDA (TTM)
-$18.59MUSD
Net Income (TTM)
-$21.17MUSD
EBITDA Margin
-107%
Profit Margin
-121%
PS Ratio
0.6
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Medical Devices
CEO
R. Huntsman open_in_new
Employees
262
Founded
2016
IPO
11 Dec 2020
Website
vivos.com open_in_new
1d 1w 1m 3m 6m 1y
-8% -24% -32% -54% -70% -71%

News

Loading...

VVOS Analyst Forecasts

Loading...

Markets

Exchange Ticker Price
NASDAQ
MIC: XNAS
PRIMARY
VVOS
Vivos Therapeutics Inc Ordinary Shares
ISIN: US92859E2072
Shares Out.:
13.895M1 Shares Float: 10.252M2
TV:
SA:
YF:
GF:
NQ:
BA:
MS:
0.7817 USD
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.

About Vivos Therapeutics, Inc.

Vivos Therapeutics, Inc. operates as a medical technology company that develops and commercializes treatment modalities for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults. It offers The Vivos Method, a non-invasive, non-surgical, non-pharmaceutical, multi-disciplinary treatment modality for the treatment of dentofacial abnormalities, OSA, and snoring. The company also offers VivoScore Program, a screening and home sleep test in adults and children. It markets and sells its appliances, and related treatments and services to licensed professionals, primarily general dentists in the United States and Canada. The company was formerly known as Vivos BioTechnologies, Inc. and changed its name to Vivos Therapeutics, Inc. in March 2018. The company was founded in 2016 and is based in Littleton, Colorado.

Similar Companies

Industry: Medical Devices (United States)
Name
Market Cap diff.
PE
$173.27B
2M%
25.8
$160.73B
2M%
56.7
$159.07B
2M%
25.6
DHR
$126.55B
1M%
34.7
SYK
$120.69B
1M%
38.3
$84.93B
806K%
24.5
Industry: Medical Devices (Global)
Name
Market Cap diff.
PE
MDT
$101.9B
967K%
22.2
$97.46B
84.32B EUR
924K%
36.7
7741
$61.41B
9.83T JPY
583K%
40.0
$45.47B
39.34B EUR
431K%
18.7
ALC
$36.38B
28.99B CHF
345K%
37.9
$30.06B
203.66B CNY
285K%
26.0
chevron_leftBack